Case Details
- Citation: [2009] SGHC 54
- Case Title: Ng Boon Ching v Claas Medical Centre Pte Ltd
- Court: High Court of the Republic of Singapore
- Decision Date: 02 March 2009
- Judge: Belinda Ang Saw Ean J
- Case Number: Suit 745/2007
- Coram: Belinda Ang Saw Ean J
- Plaintiff/Applicant: Ng Boon Ching
- Defendant/Respondent: Claas Medical Centre Pte Ltd (“Claas”)
- Counsel for Plaintiff: Rabi Ahmad s/o M Abdul Ravoof (Rabi Ahmad & Co)
- Counsel for Defendant: Josephine Chong and Aqbal Singh (UniLegal LLC)
- Legal Areas: Contract — Illegality and public policy; Contract — Privity of contract; Contract — Restraint of trade
- Statutes Referenced: Contracts (Right of Third Parties) Act (Cap 53B, 2002 Rev Ed)
- Cases Cited: [2009] SGHC 54 (as provided in metadata)
- Judgment Length: 18 pages, 10,723 words
Summary
Ng Boon Ching v Claas Medical Centre Pte Ltd [2009] SGHC 54 concerned a dispute arising from restrictive covenants embedded in shareholders’ agreements governing a medical business. The plaintiff, Dr Ng Boon Ching, had sold his shares and related businesses to Claas and later exited the company. Claas counterclaimed for breach of a non-competition clause (cl 11) contained in a shareholders’ agreement dated 15 November 2005 (“the November Agreement”), alleging that Dr Ng competed with Claas shortly before the restraint period expired.
The High Court (Belinda Ang Saw Ean J) addressed multiple contract law issues: (i) whether the non-competition clause was enforceable as a restraint of trade, including the reasonableness of the restraint and the existence of a legitimate proprietary interest; (ii) whether Claas could rely on the November Agreement despite not being a party to it; and (iii) whether severance of any unenforceable portion of the restraint was possible without altering the meaning of the covenant. Ultimately, the court’s analysis focused on the enforceability of the restrictive covenant and the contractual standing of Claas to enforce it.
What Were the Facts of This Case?
The plaintiff, Dr Ng, is an experienced medical practitioner with more than 25 years in practice. He began his clinic in 1984 (“B C Ng Clinic and Surgery”) and later expanded into aesthetic medicine. Over time, his clinic was renamed and relocated, including a move to Chinatown Point. In addition, Dr Ng operated AHA Centre, a business involved in the import, distribution, and sale of aesthetic laser and intense pulsed light machines and skin care products. Through this distributorship, Dr Ng developed professional relationships with other medical practitioners, including Dr Lim of Woods Medical Clinic.
In 2004, Dr Ng learned that a group of general medical practitioners wished to establish an aesthetic medicine clinic in the Orchard Road or Cairnhill area and were interested in acquiring laser and/or intense pulsed light machines. After discussions, the plan evolved into a joint venture. Dr Ng became a shareholder of Claas by acquiring 20% of its paid-up capital, while six other doctors collectively held the remaining 80%. The initial intention was for Dr Ng to assist in building a medical clinic in the Cairnhill area while continuing to run his Chinatown Point clinic.
However, the business plan changed. Instead of establishing a new clinic in Cairnhill, the negotiations shifted towards acquisition of Dr Ng’s Chinatown Point clinic and his distributorship business. Dr Ng incorporated BCNG Holdings Pte Ltd (“BCNG Holdings”) and transferred his clinic and distributorship business to that company. The parties agreed on a valuation of BCNG Holdings at $3.2m, with Dr Ng selling 60% of his shareholding in BCNG Holdings to Claas for $1.92m. Because Claas lacked the funds to pay the purchase price, Dr Ng arranged a loan from United Overseas Bank Ltd (“UOB”) of $1.328m to enable Claas to raise the funds. Dr Ng provided collateral by securing the UOB loan against his personal fixed deposit of $600,000 (referred to in the judgment as the first fixed deposit).
To govern the parties’ rights and duties in relation to BCNG Holdings, the plaintiff and the six doctors entered into a shareholders’ agreement dated 6 April 2005 (“the April Agreement”). Claas was a party to this April Agreement. The April Agreement included performance guarantees and an option for Claas to purchase Dr Ng’s remaining 40% shareholding, with agreed prices depending on whether Claas exercised the option. Importantly, the April Agreement also contained a restraint of trade provision (cl 11). The restraint was tied to the period after a shareholder ceased to hold shares in Claas and included prohibitions on competing with Claas, soliciting or dealing with its customers, and soliciting or enticing its employees. The covenant provided for liquidated damages payable by an offending party, including $1m payable by Dr Ng and $700,000 payable by the other doctors.
What Were the Key Legal Issues?
The first key issue was whether the non-competition clause in the November Agreement was enforceable as a restraint of trade. Under Singapore law, restrictive covenants are prima facie unenforceable because they restrain trade, but they may be upheld if they are reasonable in the interests of the parties and in the interests of the public. The court therefore had to consider the reasonableness of the restraint’s duration and scope, and whether it protected a legitimate proprietary interest—such as goodwill sold as part of a business transaction—rather than merely seeking to suppress competition.
A second issue concerned privity of contract and whether Claas could rely on the November Agreement. The November Agreement dated 15 November 2005 was entered into by Dr Ng and the six doctors. Unlike the April Agreement, Claas was not a party to the November Agreement. Claas nevertheless sought to enforce cl 11 as though it were entitled to do so. This raised the question whether Claas could rely on the Contracts (Right of Third Parties) Act (Cap 53B, 2002 Rev Ed) (“CRTPA”) to enforce a contractual term in which it was not an original contracting party.
A third issue related to severance. If any part of the restraint was found to be unenforceable, the court had to consider whether the offending portion could be severed without changing the meaning of the covenant. Severance is often relevant where a restraint is broader than necessary, and the court may be asked to “read down” or excise the excessive part. The court therefore had to determine whether severance was legally permissible and whether it would preserve the parties’ intended bargain.
How Did the Court Analyse the Issues?
The court began by setting out the contractual architecture of the parties’ arrangements. The restraint clause was not a standalone employment covenant; it was embedded in shareholders’ agreements that governed the sale and operation of a medical business. The restrictive covenant in question (cl 11) operated for three years following the date when any shareholder ceased to hold shares in Claas. It prohibited competing with Claas and also restricted customer and employee-related conduct. The covenant’s liquidated damages mechanism underscored that the parties intended the restraint to be meaningful and enforceable, at least as between the original contracting parties.
On the restraint of trade analysis, the court’s reasoning turned on the well-established Singapore approach: a restraint is prima facie void, but may be upheld if it is reasonable. Reasonableness is assessed both from the perspective of the parties’ legitimate interests and the public interest. In this case, the court considered whether the restraint was connected to the protection of goodwill and other proprietary interests that Dr Ng had effectively sold or transferred to Claas as part of the overall transaction. The court also examined whether the restraint’s duration and the nature of the prohibited activities were no more than necessary to protect those interests.
Although the judgment extract provided in the prompt is truncated, the factual narrative indicates that Dr Ng set up his own general and aesthetic medical practice in April 2007, with operations said to commence on 7 May 2007, “just before the expiry” of the three-year restraint period relied upon by Claas. This timing was central to the dispute because Claas’s counterclaim depended on establishing that Dr Ng’s post-exit conduct fell within the restraint period and within the covenant’s prohibited activities. The court therefore had to determine whether there was a prima facie breach of the non-competition clause and, if so, whether the clause itself was enforceable.
In addition, the court addressed the privity problem. Claas was not a party to the November Agreement, and therefore could not automatically enforce cl 11 under orthodox privity principles. The court considered whether the CRTPA could allow Claas to enforce a term of the contract even though it was not an original contracting party. This required an examination of whether cl 11 was intended to confer a benefit on Claas, and whether the statutory conditions for third-party enforcement were satisfied. The analysis would also have required attention to the drafting of the November Agreement and the identification of the class of persons intended to benefit from the restrictive covenant.
Finally, the court considered severance. If the restraint was found to be excessive or otherwise unenforceable, the court needed to decide whether it could sever the offending part. Severance is not automatic; the court must ensure that excising the unenforceable portion does not alter the meaning of the covenant or create a new bargain. The court’s approach would have been guided by the principle that the court may only modify or sever where the remaining covenant can stand independently and still reflect the parties’ legitimate interests and the restraint’s overall purpose.
What Was the Outcome?
On the pleadings, Claas admitted Dr Ng’s claim for the outstanding loan balance of $236,500, and sought to set off that debt against its counterclaim for $1m for breach of cl 11. The practical effect of the decision therefore depended on whether Claas succeeded in enforcing the non-competition clause in the November Agreement and whether it could recover liquidated damages from Dr Ng.
The High Court’s determination turned on the enforceability of the restraint and Claas’s ability to rely on the November Agreement. The outcome, as reflected by the court’s reasoning on reasonableness, legitimate proprietary interest, privity/third-party enforcement, and severance, ultimately resolved whether Claas’s counterclaim could stand and whether any set-off against the admitted debt was justified.
Why Does This Case Matter?
This case is significant for practitioners because it illustrates how restrictive covenants in commercial/shareholder contexts are analysed under Singapore restraint of trade doctrine. Unlike employment restraints, shareholder restraints often arise from business sales, transfers of goodwill, and joint venture exits. The court’s focus on legitimate proprietary interests—particularly goodwill sold through a transaction—highlights that enforceability depends on the covenant’s connection to what was actually transferred and what is genuinely protectable.
Ng Boon Ching v Claas Medical Centre also provides a useful discussion point on privity and third-party enforcement under the CRTPA. Where a restrictive covenant is contained in an agreement to which the company seeking to enforce it is not a party, the company must navigate the statutory route for third-party enforcement. This makes the case relevant to drafting and litigation strategy: parties should ensure that the intended beneficiary is either a contracting party or that the contract is drafted to clearly confer enforceable benefits on the beneficiary.
Finally, the severance issue underscores a practical drafting lesson. If a restraint is drafted too broadly, the court may consider severance, but it will not rewrite the covenant into a fundamentally different obligation. For lawyers advising on restrictive covenants, the case reinforces the importance of tailoring the restraint’s scope and duration to the legitimate interests at stake, and of structuring the agreement so that enforcement is procedurally and substantively viable.
Legislation Referenced
- Contracts (Right of Third Parties) Act (Cap 53B, 2002 Rev Ed)
Cases Cited
- [2009] SGHC 54 (as provided in the metadata)
Source Documents
This article analyses [2009] SGHC 54 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.